| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |